Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物效标志,被用
评估患者危险,在某些病例中也用
调整
度。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物效标志,被用
评估患者危险,在某些病例中也用
调整
度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物志,被用
评估患
,在某些病例中也用
调整治
强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工,
表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性类均由互联网资源自动生
,
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物效标志,被用
评估患者危险,在某些病例中也用
调整
度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗
。
明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标志,被用评估患者危险,在某些病例中也用
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,内容亦不代
本软件的观点;若发现问题,欢迎向我们指正。
Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.
MRD作为抗白血病药物疗效标,
者危险,在某些病例中也
调整治疗强度。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。